242 related articles for article (PubMed ID: 9377962)
1. Distinctive clinical features of portopulmonary hypertension.
Kuo PC; Plotkin JS; Johnson LB; Howell CD; Laurin JM; Bartlett ST; Rubin LJ
Chest; 1997 Oct; 112(4):980-6. PubMed ID: 9377962
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic profile of portopulmonary hypertension.
Feltracco P; Serra E; Brezzi ML; Milevoj M; Rizzi S; Furnari M; Barbieri S; Salvaterra F; Ori C
Transplant Proc; 2009 May; 41(4):1235-9. PubMed ID: 19460527
[TBL] [Abstract][Full Text] [Related]
3. Progressive portopulmonary hypertension after liver transplantation treated with epoprostenol.
Rafanan AL; Maurer J; Mehta AC; Schilz R
Chest; 2000 Nov; 118(5):1497-500. PubMed ID: 11083710
[TBL] [Abstract][Full Text] [Related]
4. Portopulmonary hypertension: hemodynamics, pulmonary angiography, and configuration of the heart.
Sakuma M; Souma S; Kitamukai O; Demachi J; Takahashi T; Suzuki J; Nawata J; Sugimura K; Oikawa M; Saji K; Tada T; Fukui S; Kagaya Y; Watanabe J; Shirato K
Circ J; 2005 Nov; 69(11):1386-93. PubMed ID: 16247216
[TBL] [Abstract][Full Text] [Related]
5. Portopulmonary hypertension: Results from a 10-year screening algorithm.
Krowka MJ; Swanson KL; Frantz RP; McGoon MD; Wiesner RH
Hepatology; 2006 Dec; 44(6):1502-10. PubMed ID: 17133488
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.
Fix OK; Bass NM; De Marco T; Merriman RB
Liver Transpl; 2007 Jun; 13(6):875-85. PubMed ID: 17539008
[TBL] [Abstract][Full Text] [Related]
7. Portopulmonary hypertension in decompensated cirrhosis with refractory ascites.
Benjaminov FS; Prentice M; Sniderman KW; Siu S; Liu P; Wong F
Gut; 2003 Sep; 52(9):1355-62. PubMed ID: 12912870
[TBL] [Abstract][Full Text] [Related]
8. Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates.
Cotton CL; Gandhi S; Vaitkus PT; Massad MG; Benedetti E; Mrtek RG; Wiley TE
Liver Transpl; 2002 Nov; 8(11):1051-4. PubMed ID: 12424719
[TBL] [Abstract][Full Text] [Related]
9. Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension.
Findlay JY; Harrison BA; Plevak DJ; Krowka MJ
Liver Transpl Surg; 1999 Sep; 5(5):381-7. PubMed ID: 10477839
[TBL] [Abstract][Full Text] [Related]
10. Plasma cytokines and portopulmonary hypertension in patients with cirrhosis waiting for orthotopic liver transplantation.
Pellicelli AM; Barbaro G; Puoti C; Guarascio P; Lusi EA; Bellis L; D'Ambrosio C; Villani R; Vennarecci G; Liotta G; Ettore G; Andreoli A
Angiology; 2010 Nov; 61(8):802-6. PubMed ID: 20498147
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension.
Austin MJ; McDougall NI; Wendon JA; Sizer E; Knisely AS; Rela M; Wilson C; Callender ME; O'Grady JG; Heneghan MA
Liver Transpl; 2008 Mar; 14(3):287-91. PubMed ID: 18306330
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study.
Colle IO; Moreau R; Godinho E; Belghiti J; Ettori F; Cohen-Solal A; Mal H; Bernuau J; Marty J; Lebrec D; Valla D; Durand F
Hepatology; 2003 Feb; 37(2):401-9. PubMed ID: 12540791
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy for severe portopulmonary hypertension in a child allows for liver transplantation.
Serrano RM; Subbarao GC; Mangus RS; Montgomery G; Johansen M
Pediatr Transplant; 2019 Aug; 23(5):e13461. PubMed ID: 31062925
[TBL] [Abstract][Full Text] [Related]
14. Arterial oxygenation associated with portopulmonary hypertension.
Swanson KL; Krowka MJ
Chest; 2002 Jun; 121(6):1869-75. PubMed ID: 12065351
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamics and survival of patients with portopulmonary hypertension.
Kawut SM; Taichman DB; Ahya VN; Kaplan S; Archer-Chicko CL; Kimmel SE; Palevsky HI
Liver Transpl; 2005 Sep; 11(9):1107-11. PubMed ID: 16123953
[TBL] [Abstract][Full Text] [Related]
16. Portopulmonary Hypertension and Liver Transplant: Recent Review of the Literature.
Cosarderelioglu C; Cosar AM; Gurakar M; Pustavoitau A; Russell SD; Dagher NN; Gurakar A
Exp Clin Transplant; 2016 Apr; 14(2):113-20. PubMed ID: 27015528
[TBL] [Abstract][Full Text] [Related]
17. Effect of pH and PCO2 on pulmonary and systemic hemodynamics after surgery in children with congenital heart disease and pulmonary hypertension.
Morray JP; Lynn AM; Mansfield PB
J Pediatr; 1988 Sep; 113(3):474-9. PubMed ID: 3137318
[TBL] [Abstract][Full Text] [Related]
18. Living-donor liver transplantation for moderate or severe porto-pulmonary hypertension accompanied by pulmonary arterial hypertension: a single-centre experience over 2 decades in Japan.
Ogawa E; Hori T; Doi H; Segawa H; Uemoto S
J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):638-49. PubMed ID: 22086457
[TBL] [Abstract][Full Text] [Related]
19. Portopulmonary hypertension in pediatric patients.
Condino AA; Ivy DD; O'Connor JA; Narkewicz MR; Mengshol S; Whitworth JR; Claussen L; Doran A; Sokol RJ
J Pediatr; 2005 Jul; 147(1):20-6. PubMed ID: 16027687
[TBL] [Abstract][Full Text] [Related]
20. The impact of treatment of portopulmonary hypertension on survival following liver transplantation.
Ashfaq M; Chinnakotla S; Rogers L; Ausloos K; Saadeh S; Klintmalm GB; Ramsay M; Davis GL
Am J Transplant; 2007 May; 7(5):1258-64. PubMed ID: 17286619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
